Baidu
map

PLoS One:阿莫西林和甲硝唑辅助龈下刮治的效果如何?

2017-07-22 MedSci MedSci原创

本研究旨在评价重度牙周炎患者经龈下刮治后,联合阿莫西林和甲硝唑全身用药辅助治疗后12个月后的临床结果。研究共纳入了102名重度牙周炎患者,将其随机分为:连续2天内进行龈下刮治,然后使用安慰剂治疗7天(A组);龈下刮治+阿莫西林+甲硝唑(500mg ,每日3次)3天(B组);龈下刮治+阿莫西林+甲硝唑(500mg ,每日3次)7天(C组)。基线时期,以及治疗后3、6和12个月时评估患者的牙周袋深度(

本研究旨在评价重度牙周炎患者经龈下刮治后,联合阿莫西林和甲硝唑全身用药辅助治疗后12个月后的临床结果。

研究共纳入了102名重度牙周炎患者,将其随机分为:连续2天内进行龈下刮治,然后使用安慰剂治疗7天(A组);龈下刮治+阿莫西林+甲硝唑(500mg ,每日3次)3天(B组);龈下刮治+阿莫西林+甲硝唑(500mg ,每日3次)7天(C组)。基线时期,以及治疗后3、6和12个月时评估患者的牙周袋深度(PD)、临床附着水平(CAL)、根分叉病变、探诊出血(BOP)、全口菌斑(FMPS)。PD≥6mm位点数量的减少是主要结果变量。

结果,75名患者完成了这项研究。在12个月时,与基线时期相比,所有治疗组的平均PD、CAL、BOP、PD≥6mm位点的数量均有统计学改善(P<0.001)。与安慰剂组相比,两种抗生素组平均PD不合格的位点显著减少,而CAL显著增加。虽然与A组相比C组的PD减少(P = 0.012)和CAL增加(P = 0.017)明显升高,但是仅有B组12个月时PD≥6mm位点较少(P = 0.003)。3组之间PD≥6 mm的位点数量的减少(主要终点)均无明显统计学差异。然而,与安慰剂组相比,抗生素组患者治疗后12个月后疾病进展的风险较低(PD≥5mm的位点≤4)。

总而言之,该研究结果表明,治疗后12个月时,与安慰剂组相比,两种抗生素辅助治疗方案的临床症状改善更显著。

原始出处:

Raluca Cosgarea, Christian Heumann, et al., One year results of a randomized controlled clinical study evaluating the effects of non-surgical periodontal therapy of chronic periodontitis in conjunction with three or seven days systemic administration of amoxicillin/metronidazole. PLoS One. 2017; 12(6): e0179592. Published online 2017 Jun 29. doi: 10.1371/journal.pone.0179592.
本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1822575, encodeId=e61518225e598, content=<a href='/topic/show?id=3aa51035644d' target=_blank style='color:#2F92EE;'>#龈下刮治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103564, encryptionId=3aa51035644d, topicName=龈下刮治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Thu Oct 19 19:36:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790002, encodeId=ed2b1e90002a4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Oct 07 09:36:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299284, encodeId=3c731299284cc, content=<a href='/topic/show?id=5413699307e' target=_blank style='color:#2F92EE;'>#甲硝唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69930, encryptionId=5413699307e, topicName=甲硝唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Mon Jul 24 02:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225104, encodeId=e15c2251040e, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Jul 22 13:47:19 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1822575, encodeId=e61518225e598, content=<a href='/topic/show?id=3aa51035644d' target=_blank style='color:#2F92EE;'>#龈下刮治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103564, encryptionId=3aa51035644d, topicName=龈下刮治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Thu Oct 19 19:36:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790002, encodeId=ed2b1e90002a4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Oct 07 09:36:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299284, encodeId=3c731299284cc, content=<a href='/topic/show?id=5413699307e' target=_blank style='color:#2F92EE;'>#甲硝唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69930, encryptionId=5413699307e, topicName=甲硝唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Mon Jul 24 02:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225104, encodeId=e15c2251040e, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Jul 22 13:47:19 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1822575, encodeId=e61518225e598, content=<a href='/topic/show?id=3aa51035644d' target=_blank style='color:#2F92EE;'>#龈下刮治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103564, encryptionId=3aa51035644d, topicName=龈下刮治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Thu Oct 19 19:36:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790002, encodeId=ed2b1e90002a4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Oct 07 09:36:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299284, encodeId=3c731299284cc, content=<a href='/topic/show?id=5413699307e' target=_blank style='color:#2F92EE;'>#甲硝唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69930, encryptionId=5413699307e, topicName=甲硝唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Mon Jul 24 02:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225104, encodeId=e15c2251040e, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Jul 22 13:47:19 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
    2017-07-24 whmdzju
  4. [GetPortalCommentsPageByObjectIdResponse(id=1822575, encodeId=e61518225e598, content=<a href='/topic/show?id=3aa51035644d' target=_blank style='color:#2F92EE;'>#龈下刮治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103564, encryptionId=3aa51035644d, topicName=龈下刮治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a6b240, createdName=俅侠, createdTime=Thu Oct 19 19:36:00 CST 2017, time=2017-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790002, encodeId=ed2b1e90002a4, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Oct 07 09:36:00 CST 2017, time=2017-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299284, encodeId=3c731299284cc, content=<a href='/topic/show?id=5413699307e' target=_blank style='color:#2F92EE;'>#甲硝唑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69930, encryptionId=5413699307e, topicName=甲硝唑)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Mon Jul 24 02:36:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225104, encodeId=e15c2251040e, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sat Jul 22 13:47:19 CST 2017, time=2017-07-22, status=1, ipAttribution=)]
    2017-07-22 Y—xianghai

    学习了新知识

    0

相关资讯

J Antimicrob Chemother :阿莫西林比克林霉素更能有效预防感染性心内膜炎

J Antimicrob Chemother :阿莫西林比克林霉素更能有效地预防感染性心内膜炎的发生英国的一项新研究表明患者在接受牙科之前预防性使用阿莫西林来预防感染性心内膜炎发生的效果优于克林霉素。该研究于2015年4月29日在线发表于J Antimicrob Chemother. 牙科治疗之前预防性使用抗生素一直是预防感染性心内膜炎发生的主要手段,然而,预防性使用抗生素却存在着诸多的

呼吸急促的小婴儿:口服阿莫西林更有效

世卫组织建议可能的严重的细菌感染的年龄为0-59天的小婴儿转诊至医院进行治疗。我们的目的是评估口服阿莫西林治疗呼吸急促,在没有其他标志的情况下,是否与联合注射用普鲁卡因青霉素和庆大霉素同样有效。 方法 一项随机,开放标签,等效性试验中在刚果民主共和国,肯尼亚和尼日利亚的五个站点进行,社区卫生工作者对所有出生在社区的婴儿,并确定不适的婴幼儿进行了随访。我们随机将婴儿分配呼吸急促生病或可能导致严重的

J Dent Res:甲硝唑联合阿莫西林全身用药可显著改善伴有2型糖尿病的牙周炎患者的SRP治疗结果

J Dent Res:甲硝唑联合阿莫西林全身用药可显著改善伴有2型糖尿病的牙周炎患者的SRP治疗结果本研究旨在评估伴有2型糖尿病(DM)的牙周炎患者经洁治和根面平整(SRP)或联合甲硝唑和阿莫西林全身用药后其龈下生物膜的组成及牙周临床指标的变化。研究共纳入了58名受试者,随机分配至SRP治疗组(n = 29)或SRP+甲硝唑(400 mg /TID)+阿莫西林(500毫克/TID)治疗组(n =

又有逼格又好用的挡酒理由。。。

新春佳节将至,各种聚会接踵而至,和朋友小酌必不可少。把酒言欢之余,需谨记服用哪些药物期间不能饮酒。双硫仑样反应 头孢类药物+饮酒         1948年有人发现,作为橡胶的硫化催化剂双硫仑被人体微量吸收后,能引起面部潮红、头痛、腹痛、出汗、心悸、呼吸困难等症状,尤其是在饮酒后症状会更加明显。为此,人们把这种在接触

阿莫西林2次/日与3次/日对小儿轻症肺炎同样有效

门诊中标准的阿莫西林口服(50mg/Kg/天)每日3次为小儿非重症肺炎的一线治疗方案。更少的服药次数可能意味着更高的依从性,但是目前尚无对每日2次或每日3次的治疗方案的直接比较研究。 来自巴西的Nascimento-Carvalho博士等对此展开研究。结果表明,对于小儿轻症肺炎,每日2次口服剂量的阿莫西林与每日3次同样有效。该研究在线发表在2014年3月19日的Antimicrobial Chem

中国河流抗生素地图发布 阿莫西林浓度**

  中国抗生素污染总体情况到底如何?终于有了研究成果。近日,中国科学院广州地球化学研究所应光国课题组获取首份中国抗生素使用量和排放量清单,预测得出全国5 8个流域的“抗生素环境浓度地图”。这一报告于6月初发表在国际学术期刊《环境科学与技术》。   近年多地河流水体被检出抗生素,已经引起人们的广泛关注。去年12月,央视曝光全国主要河流部分点位都检出抗生素,甚至南京居民家中自来水也有检出。其

Baidu
map
Baidu
map
Baidu
map